tiprankstipranks
Company Announcements

SciSparc Announces Intent to Sell MitoCareX Stake

SciSparc Announces Intent to Sell MitoCareX Stake

SciSparc Ltd. (SPRC) has released an update.

SciSparc Ltd., a clinical-stage pharmaceutical company specializing in central nervous system disorders, has announced a non-binding letter of intent to sell its majority stake in MitoCareX Bio for a potential total of $8 million, reflecting a 47% increase in valuation since its initial investment. The transaction, which includes milestone-based increments to the consideration, is aimed at enhancing shareholder value and aligns with SciSparc’s strategic focus on investment and partnership opportunities.

For further insights into SPRC stock, check out TipRanks’ Stock Analysis page.

Questions or Comments about the article? Write to editor@tipranks.com
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1